Amputations for extremity soft tissue sarcoma in an era of limb salvage treatment: Local control and survival

Journal of Surgical Oncology - Tập 117 Số 3 - Trang 434-442 - 2018
Marc G. Stevenson1, Annelie H. Musters1, Jan H. B. Geertzen2, Barbara L. van Leeuwen1, Harald J. Hoekstra1, Lukas B. Been
1Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
2Department of Rehabilitation Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Tóm tắt

BackgroundDespite multimodality limb salvage treatment (LST) for locally advanced extremity soft tissue sarcoma (ESTS), some patients still need an amputation. Indications for amputation and oncological outcome for these patients are described.MethodsBetween 1996 and 2016, all patients who underwent an amputation for ESTS were included. Patients who underwent an amputation as primary or as non‐primary treatment formed Group I and II, respectively.ResultsThirty‐nine patients were included, 16 in Group I (41%) and 23 in Group II (59%). Tumor size or local recurrence which could not be treated with LST were the two main reasons for amputation. Local recurrence free survival (LRFS) (P = 0.396), distant metastases free survival (DMFS) (P = 0.965), disease‐specific survival (DSS) (P = 0.745), and overall survival (OS) (P = 0.718) were comparable for both groups. Ten‐year LRFS was 90.0% versus 83.7%; DMFS was 31.0% versus 42.2%; DSS was 52.2% versus 44.1%; and OS was 44.2% versus 41.6%, for group I and II respectively.ConclusionsOncological outcome seems to be comparable between patients who underwent a primary or a non‐primary amputation for ESTS. With the on‐going possibilities concerning prosthesis and rehabilitation programs, it remains important to decide in a multidisciplinary sarcoma team meeting which treatment suits best for each individual patient.

Từ khóa


Tài liệu tham khảo

10.3322/caac.21332

Soft Tissue Sarcoma incidence Nederlandse Kankerregistratie beheerd door IKNL © [May] 2017 2016;2017.

Soft Tissue Sarcoma deaths Nederlandse Kankerregistratie beheerd door IKNL © [May] 2017 2016;2017.

Fletcher CDM, 2013, WHO Classification of Tumours of Soft Tissue and Bone

10.1016/j.ejso.2012.08.024

10.1186/1477-7819-7-15

10.1080/08998280.2003.11927915

2000, Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta‐analysis Collaboration (SMAC), Cochrane Database Syst Rev, CD001419

10.1093/annonc/mdu460

10.1016/j.ejca.2016.09.030

10.1097/00000658-198209000-00009

10.1200/JCO.1998.16.1.197

10.1016/S0140-6736(02)09292-9

10.1007/s10434-004-1171-3

10.1016/j.ctrv.2012.10.005

10.1016/S0167-8140(99)00003-1

10.1016/S1470-2045(03)01113-6

Malawer MM, 2001, Musculoskeletal Cancer Surgery Treatment of Sarcomas and Allied Diseases, 10.1007/0-306-48407-2

10.1016/j.ijrobp.2012.01.062

10.1200/JCO.1996.14.10.2653

Hoven‐Gondrie ML, 2013, Limb perfusion in soft tissue sarcomas: twenty years of experience, Ned Tijdschr Geneeskd, 157, A6148

10.1002/jso.21885

10.1016/j.ejso.2012.12.018

10.1002/bjs.4004

10.1007/s10434-001-0509-3

Soft Tissue Sarcoma survival Nederlandse Kankerregistratie beheerd door IKNL © [May] 2017 2017;2017.

10.1007/s00776-014-0689-x

10.5435/JAAOS-D-15-00074

Smith HG, 2017, Major amputations for extremity soft‐tissue sarcoma, Ann Surg Oncol

10.1245/ASO.2006.05.023

Sugarbaker PH, 1982, Quality of life assessment of patients in extremity sarcoma clinical trials, Surgery, 91, 17

10.1007/s00402-014-2086-5

10.1080/13577140120099173

Branemark R, 2001, Osseointegration in skeletal reconstruction and rehabilitation: a review, J Rehabil Res Dev, 38, 175

10.1016/j.apmr.2014.07.009

10.1177/0309364614541460

10.1177/0309364614542725

The Rehabilitation of Lower Limb Amputation Working Group Department of Veterans Affairs Department of Defense: VA/DoD Clinical Practice Guideline For Rehabilitation of Lower Limb Amputation. Version 1.02007.

10.1002/jso.20779

10.1002/jso.23830

Thông tin
Thông tin xuất bản

Journal of Surgical Oncology

Tập 117 Số 3

434-442

Thông tin tác giả